Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
High levels of methylated DNA in urine represent an emerging biomarker for non-small cell lung cancer (NSCLC) detection and are the subject of ongoing research. This study aimed to investigate the circadian variation of urinary cell-free DNA (cfDNA) abundance and methylation levels of cancer-associa...
| Published in: | Epigenetics |
|---|---|
| Main Authors: | Sander Bach, Birgit M.M. Wever, Mark A. van de Wiel, Joris D. Veltman, Sayed M.S. Hashemi, Geert Kazemier, Idris Bahce, Renske D.M. Steenbergen |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-10-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/15592294.2021.1982511 |
Similar Items
Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities
by: Birgit M. M. Wever, et al.
Published: (2025-07-01)
by: Birgit M. M. Wever, et al.
Published: (2025-07-01)
Urine-Based Cell-Free DNA Tests in Urothelial Cancer: Additional Value for Clinical Decision-Making?
by: Lars Dyrskjøt
Published: (2023-07-01)
by: Lars Dyrskjøt
Published: (2023-07-01)
The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine
by: Ivonne Nel, et al.
Published: (2023-12-01)
by: Ivonne Nel, et al.
Published: (2023-12-01)
Weekly Biological Variation of Urine Protein Creatinine Ratio and Urine Specific Gravity in Healthy Dogs
by: Yanick Couture, et al.
Published: (2025-03-01)
by: Yanick Couture, et al.
Published: (2025-03-01)
Bladder cancer detection in urine by novel methylation markers
by: Irene J. Beijert, et al.
Published: (2024-11-01)
by: Irene J. Beijert, et al.
Published: (2024-11-01)
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
by: Hongwei Peng, et al.
Published: (2024-05-01)
by: Hongwei Peng, et al.
Published: (2024-05-01)
Screening aging related proteins in urine from healthy adults
by: ZHENG Shu-xin, ZHAO Min-di, SHAO Chen, SUN Hai-dan, LIU Xiao-yan, GUO Zheng-guang, SUN Wei
Published: (2021-04-01)
by: ZHENG Shu-xin, ZHAO Min-di, SHAO Chen, SUN Hai-dan, LIU Xiao-yan, GUO Zheng-guang, SUN Wei
Published: (2021-04-01)
Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis
by: Nicholas Kueng, et al.
Published: (2023-07-01)
by: Nicholas Kueng, et al.
Published: (2023-07-01)
Effect of centrifugal conditions on urine protein extraction by acetone precipitation method
by: LI Jing, ZHOU Dong-dong, SUN Wei
Published: (2020-02-01)
by: LI Jing, ZHOU Dong-dong, SUN Wei
Published: (2020-02-01)
Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
by: Xiaolu Zhang, et al.
Published: (2024-04-01)
by: Xiaolu Zhang, et al.
Published: (2024-04-01)
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer
by: Florian Janke, et al.
Published: (2025-03-01)
by: Florian Janke, et al.
Published: (2025-03-01)
Copy number variations in urine cell-free DNA from bladder neoplasm patients
by: Cuello Garcia Haider, et al.
Published: (2025-10-01)
by: Cuello Garcia Haider, et al.
Published: (2025-10-01)
Diurnal and daily fluctuations in levels of the urinary oxidative stress marker 8-hydroxyguanosine in spot urine samples
by: Yun-Shan Li, et al.
Published: (2025-01-01)
by: Yun-Shan Li, et al.
Published: (2025-01-01)
A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
by: Haichao Wang, et al.
Published: (2025-05-01)
by: Haichao Wang, et al.
Published: (2025-05-01)
Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal Cancer
by: Zhiping Long, et al.
Published: (2024-08-01)
by: Zhiping Long, et al.
Published: (2024-08-01)
Urine Biomarkers for Prostate Cancer Diagnosis and Progression
by: Jeremy Clark, Rachel Hurst, Mark Simon Winterbone, Hardev Pandha, Antoinette Perry, Sophie McGrath, Richard Morgan, Adele E Connor, Asia C Jordan, Deirdre Winrow, Colin Cooper
Published: (2021-05-01)
by: Jeremy Clark, Rachel Hurst, Mark Simon Winterbone, Hardev Pandha, Antoinette Perry, Sophie McGrath, Richard Morgan, Adele E Connor, Asia C Jordan, Deirdre Winrow, Colin Cooper
Published: (2021-05-01)
Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detectionResearch in context
by: Su-Fang Qiu, et al.
Published: (2024-10-01)
by: Su-Fang Qiu, et al.
Published: (2024-10-01)
OncoCan: a liquid biopsy assay for cell-free DNA quantification in canine plasma to support cancer prognosis
by: Virginia Sánchez, et al.
Published: (2026-02-01)
by: Virginia Sánchez, et al.
Published: (2026-02-01)
Correction: OncoCan: a liquid biopsy assay for cell-free DNA quantification in canine plasma to support cancer prognosis
by: Virginia Sánchez, et al.
Published: (2026-04-01)
by: Virginia Sánchez, et al.
Published: (2026-04-01)
The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)
by: Hussein Adil Abid, et al.
Published: (2024-01-01)
Real‐time analysis of the cancer genome and fragmentome from plasma and urine cell‐free DNA using nanopore sequencing
by: Ymke van der Pol, et al.
Published: (2023-11-01)
by: Ymke van der Pol, et al.
Published: (2023-11-01)
Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
by: Verena Lieb, et al.
Published: (2021-11-01)
by: Verena Lieb, et al.
Published: (2021-11-01)
Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line
by: Vida Ungerer, et al.
Published: (2022-08-01)
by: Vida Ungerer, et al.
Published: (2022-08-01)
Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine
by: Laura Téblick, et al.
Published: (2021-04-01)
by: Laura Téblick, et al.
Published: (2021-04-01)
Urine Sampling Protocol Recommendations for Reliable Determination of Total Urinary Luteinizing Hormone Immunoreactivity in the Pediatric Population
by: And Demir, et al.
Published: (2023-12-01)
by: And Demir, et al.
Published: (2023-12-01)
Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
by: Patricia Mondelo-Macía, et al.
Published: (2021-01-01)
by: Patricia Mondelo-Macía, et al.
Published: (2021-01-01)
Multimodal analysis of cell-free DNA to improve early detection of gastric cancer
by: Vo Duy Long, et al.
Published: (2026-02-01)
by: Vo Duy Long, et al.
Published: (2026-02-01)
The influence of urine cytology on our practice
by: Mahmoud Alameddine, et al.
Published: (2012-01-01)
by: Mahmoud Alameddine, et al.
Published: (2012-01-01)
Atypical cells parameter in sysmex UN automated urine analyzer: a single center study
by: Aydin Ozgur, et al.
Published: (2024-12-01)
by: Aydin Ozgur, et al.
Published: (2024-12-01)
Liquid biopsy: Cell-free DNA based analysis in breast cancer
by: Konstantinos Venetis, et al.
Published: (2023-09-01)
by: Konstantinos Venetis, et al.
Published: (2023-09-01)
Urine microbiome in individuals with an impaired immune system
by: Noha S. Elsayed, et al.
Published: (2024-01-01)
by: Noha S. Elsayed, et al.
Published: (2024-01-01)
DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
by: Lukas Vrba, et al.
Published: (2020-04-01)
by: Lukas Vrba, et al.
Published: (2020-04-01)
Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individuals
by: Thi Tuong Vi Van, et al.
Published: (2025-08-01)
by: Thi Tuong Vi Van, et al.
Published: (2025-08-01)
Cell-free DNA in medium is associated with the maturation ability of in vitro cultured oocytes
by: Yasuhisa MUNAKATA, et al.
Published: (2019-02-01)
by: Yasuhisa MUNAKATA, et al.
Published: (2019-02-01)
Urine cell-based DNA methylation classifier for monitoring bladder cancer
by: Antoine G. van der Heijden, et al.
Published: (2018-05-01)
by: Antoine G. van der Heijden, et al.
Published: (2018-05-01)
Influencing factors on the NMP-22 urine assay: an experimental model
by: Miyake Makito, et al.
Published: (2012-08-01)
by: Miyake Makito, et al.
Published: (2012-08-01)
Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
by: Zhong Y, et al.
Published: (2020-05-01)
by: Zhong Y, et al.
Published: (2020-05-01)
Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing
by: Anelis Maria Marin, et al.
Published: (2026-03-01)
by: Anelis Maria Marin, et al.
Published: (2026-03-01)
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample
by: Carmela Nardelli, et al.
Published: (2024-01-01)
by: Carmela Nardelli, et al.
Published: (2024-01-01)
Identification of cortactin molecular forms in human urine and their possible diagnostic value
by: M. Starykovych, et al.
Published: (2021-08-01)
by: M. Starykovych, et al.
Published: (2021-08-01)
Similar Items
-
Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunities
by: Birgit M. M. Wever, et al.
Published: (2025-07-01) -
Urine-Based Cell-Free DNA Tests in Urothelial Cancer: Additional Value for Clinical Decision-Making?
by: Lars Dyrskjøt
Published: (2023-07-01) -
The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine
by: Ivonne Nel, et al.
Published: (2023-12-01) -
Weekly Biological Variation of Urine Protein Creatinine Ratio and Urine Specific Gravity in Healthy Dogs
by: Yanick Couture, et al.
Published: (2025-03-01) -
Bladder cancer detection in urine by novel methylation markers
by: Irene J. Beijert, et al.
Published: (2024-11-01)
